We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Switching to Real-Time Audits As Part of Its BIMO Initiative
FDA Switching to Real-Time Audits As Part of Its BIMO Initiative
October 27, 2010
Reversing its recent practice, the FDA is once again conducting real-time inspections of clinical trials, rather than waiting until after it receives an approval application for a drug or device.